HeartBeam Inc
Research HeartBeam Inc (BEAT) on Bullrun: market cap USD 28.34M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBEAT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Market capUSD 28.34M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 4.70M
- Free cash flow-USD 3.86M
Valuation Snapshot
latest market cap is USD 28.34M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 21.02M | -USD 14.59M | n/a | -0.62 | USD 4.38M | n/a | USD 2.60M |
| FY2024 | USD 0 | -USD 19.45M | -USD 14.67M | n/a | -0.73 | USD 2.38M | n/a | USD 1.65M |
| FY2023 | n/a | -USD 14.64M | -USD 12.35M | n/a | -0.72 | USD 16.19M | n/a | USD 15.94M |
| FY2022 | n/a | -USD 12.96M | -USD 9.95M | n/a | -1.59 | USD 3.59M | n/a | USD 2.37M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 28.34M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 96.28M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 62.01M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 61.87M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 39.06M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 24.05M | n/a | n/a | n/a |
About HeartBeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HeartBeam Inc's market cap?
HeartBeam Inc's market capitalization is USD 28.34M.
What does HeartBeam Inc do?
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms.